Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keiji Nogami

Showing results (1-10 of 257) with videos related to

Pageof 26
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 5, 2021
[Update on factor (F) VIII structure and function-related hemostatic coagulation and its regulatory mechanism (s)]Keiji Nogami
Seminars in Thrombosis and Hemostasis|September 29, 2022
Clot Waveform Analysis for Monitoring HemostasisKeiji Nogami
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 6, 2017
Future prospects of hemostatic treatment for hemophilia patientsKeiji Nogami
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 8, 2016
A bispecific antibody mimicking factor VIII in hemophilia A therapyKeiji Nogami
British Journal of Haematology|June 7, 2016
The utility of thromboelastography in inherited and acquired bleeding disordersKeiji Nogami
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 9, 2021
[Current developments in hemostatic treatment for patients with hemophilia]Keiji Nogami
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 26, 2013
[Acquired coagulant factor inhibitors]Keiji Nogami
Thrombosis Research|May 22, 2016
Bispecific antibody mimicking factor VIIIKeiji Nogami
Journal of Thrombosis and Haemostasis : JTH|February 2, 2019
Routine measurements of factor VIII activity and inhibitor titer in the presence of emicizumab utilizing anti-idiotype monoclonal antibodies: replyKeiji Nogami
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 7, 2019
[Emicizumab, a bispecific antibody mimicking factor VIII: a novel alternative therapy for hemophilia A with inhibitors]Keiji Nogami
Pageof 26

Showing results (1-10 of 257) with videos related to

Sort By:
Pageof 26
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 5, 2021
[Update on factor (F) VIII structure and function-related hemostatic coagulation and its regulatory mechanism (s)]Keiji Nogami
Seminars in Thrombosis and Hemostasis|September 29, 2022
Clot Waveform Analysis for Monitoring HemostasisKeiji Nogami
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 6, 2017
Future prospects of hemostatic treatment for hemophilia patientsKeiji Nogami
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 8, 2016
A bispecific antibody mimicking factor VIII in hemophilia A therapyKeiji Nogami
British Journal of Haematology|June 7, 2016
The utility of thromboelastography in inherited and acquired bleeding disordersKeiji Nogami
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 9, 2021
[Current developments in hemostatic treatment for patients with hemophilia]Keiji Nogami
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 26, 2013
[Acquired coagulant factor inhibitors]Keiji Nogami
Thrombosis Research|May 22, 2016
Bispecific antibody mimicking factor VIIIKeiji Nogami
Journal of Thrombosis and Haemostasis : JTH|February 2, 2019
Routine measurements of factor VIII activity and inhibitor titer in the presence of emicizumab utilizing anti-idiotype monoclonal antibodies: replyKeiji Nogami
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 7, 2019
[Emicizumab, a bispecific antibody mimicking factor VIII: a novel alternative therapy for hemophilia A with inhibitors]Keiji Nogami
Pageof 26